TY - JOUR AU - Demchuk, A. V. PY - 2017/03/31 Y2 - 2024/03/29 TI - Pharmacoeconomic ABC- and VEN- analyses of treatment of community -acquired pneumonia patients with comorbidities JF - Biomedical and Biosocial Anthropology JA - Biomed. and Biosoc. Anthrop. VL - 0 IS - 26 SE - CLINICAL ARTICLES DO - UR - https://bba-journal.com/index.php/journal/article/view/149 SP - 121-124 AB - The estimation of economic rationality treatment costs of community-acquired pneumonia patients with comorbidities was performed using ABC- and VEN-analyses. It was established financial resources use is partial rational, because most of expenses are used for vital medicines, but non-essential pathogenical drugs for treatment of CAP patients with comorbidities are included into group. These medicines increase treatment cost in average 108,5 UHR/patient without improvement of clinical effectiveness of therapy. ER -